TICKERNOMICS Sign up
Last Update: 2024-03-28 02:11:41
RxSight Inc. ( RXST ) https://www.rxsight.com
49.14USD
Sector:
Healthcare
Industry:
Medical Devices
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
31.15%
RXST
200.92%
SPY
32.74%
RXST
0.00%
SPY
92.93%
RXST
0.00%
SPY
224.41%
RXST
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
1775.90
1656.73
0.35
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-31.34
20.88
11.07
-4.54
0.00
-34.88
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-40.80
44.77
-47.68
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.27
-116.10
-33.98
0.00
Other Earnings and Cash Flow Stats:
RxSight Inc. ( RXST ) Net Income TTM ($MM) is -60.54
RxSight Inc. ( RXST ) Operating Income TTM ($MM) is -56.56
RxSight Inc. ( RXST ) Owners' Earnings Annual ($MM) is 0.00
RxSight Inc. ( RXST ) Current Price to Owners' Earnings ratio is 0.00
RxSight Inc. ( RXST ) EBITDA TTM ($MM) is -52.10
RxSight Inc. ( RXST ) EBITDA Margin is -47.68%
Capital Allocation:
RxSight Inc. ( RXST ) has paid 0.00 dividends per share and bought back -8.477531 million shares in the past 12 months
RxSight Inc. ( RXST ) has reduced its debt by 44.108 million USD in the last 12 months
Capital Structure:
RxSight Inc. ( RXST ) Interest-bearing Debt ($MM) as of last quarter is 2
RxSight Inc. ( RXST ) Annual Working Capital Investments ($MM) are -19
RxSight Inc. ( RXST ) Book Value ($MM) as of last quarter is 160
RxSight Inc. ( RXST ) Debt/Capital as of last quarter is 1%
Other Balance Sheet Stats:
RxSight Inc. ( RXST ) has 9 million in cash on hand as of last quarter
RxSight Inc. ( RXST ) has 20 million of liabilities due within 12 months, and long term debt 19 as of last quarter
RxSight Inc. ( RXST ) has 36 common shares outstanding as of last quarter
RxSight Inc. ( RXST ) has 0 million USD of preferred stock value
Academic Scores:
RxSight Inc. ( RXST ) Altman Z-Score is 44.04 as of last quarter
RxSight Inc. ( RXST ) Piotroski Score is 5.00 as of last quarter
Corporate Governance:
RxSight Inc. ( RXST ) largest shareholder is owning shares at 0.00 ($MM) value
Shelley B Thunen(an insider) Sold 10000 shares of RxSight Inc. ( RXST ) for the amount of $563700.00 on 2024-03-01
14.08% of RxSight Inc. ( RXST ) is held by insiders, and 63.02% is held by institutions
RxSight Inc. ( RXST ) went public on 2021-07-30
Other RxSight Inc. ( RXST ) financial metrics:
FCF:-57.13
Unlevered Free Cash Flow:-18.68
EPS:-1.37
Operating Margin:-40.80
Gross Profit Margin:44.77
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-30.97
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About RxSight Inc. ( RXST ) :
RxSight, Inc., an ophthalmic medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.